Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

European Journal of Neuroscience

Volumn 20, Issue 7, 2004, Pages 1849-1857

  Viganò, Daniela ^a   Valenti, Marta ^b   Cascio, Maria Grazia ^b   Di Marzo, Vincenzo ^b   Parolaro, Daniela ^a   Rubino, Tiziana ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b CNR   (Italy)

Author keywords

2 arachidonoylglycerol; Anandamide; Cerebral areas; Opioid seeking behaviour

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; MORPHINE; OPIATE; RIMONABANT;

ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG SENSITIZATION; DRUG TOLERANCE; DRUG WITHDRAWAL; HIPPOCAMPUS; MALE; NEUROCHEMISTRY; NOCICEPTION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR BLOCKING; REWARD;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; MORPHINE; PIPERIDINES; PYRAZOLES; RATS; RECEPTORS, CANNABINOID;

EID: 8144228129     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03645.x     Document Type: Article

References (49)

1. Basavarajappa, B.S. & Hungund, B.L. (2002) Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview. Prostaglandins Leukot. Essent. Fatty Acids, 66, 287-299.
2. Berke, J.D. & Eichenbaum, H.B. (2001) Drug addiction and the hippocampus. Science, 294, 1235.
3. Bisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, A.J., Fernandez-Ruiz, J.J. & Di Marzo, V. (1999) Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun., 256, 377-380.
4. Cadoni, C. & Di Chiara, G. (1999) Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience, 90, 447-455.
5. Cadoni, C., Pisanu, A., Solinas, M., Acquas, E. & Di Chiara, G. (2001) Behavioral sensitization after repeated exposure to delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology, 158, 259-266.
6. Castane, A., Valjent, E., Ledent, C., Parmentier, M., Maldonado, R. & Valverde, O. (2002) Lack of CB1 cannabinoid receptors modifies nicotine behavioral responses, but not nicotine abstinence. Neuropharmacology, 43, 857-867.
7. Cohen, C., Perrault, G., Voltz, C., Steinberg, R. & Soubrie, P. (2002) SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav. Pharmacol., 13, 451-463.
8. Cossu, G., Ledent, C., Fattore, L., Imperato, A., Bohme, G.A., Parmentier, M. & Fratta, W. (2001) Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav. Brain Res., 118, 61-65.
9. De Vries, T.J., Homberg, J.R., Binnekade, R., Raaso, H. & Schoffelmeer, A.N. (2003) Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology, 168, 164-169.
10. De Vries, T.J., Schoffelmeer, A.N., Binnekade, R., Mulder, A.H. & Vanderschuren, L.J. (1998) Drug-induced reinstatement of heroin- and cocaine-seeking behavior following long-term extinction is associated with expression of behavioral sensitization. Eur. J. Neurosci., 10, 3565-3571.
11. De Vries, T.J., Shanam, Y., Homberg, J.R., Crombag, H., Schhrmann, K., Dieben, J., Vanderschuren, L.J.M.J. & Schoffelmeer, A.N.M. (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nature Med., 7, 1151-1154.
12. Deadwyler, S.A., Hayashizaki, S., Cheer, J. & Hampson, R.E. (2004) Reward, memory and substance abuse: functional neuronal circuits in the nucleus accumbens. Neurosci. Biobehav. Rev., 27, 703-711.
13. Del Arco, I., Navarro, M., Bilbao, A., Ferrer, B., Pomelli, D. & Rodriguez De Fonseca, F. (2002) Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404. Eur. J. Pharmacol., 454, 103-104.
14. Devane, W.A., Hanus, L., Bruer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
15. Di Chiara, G. (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav. Brain Res., 137, 75-114.
16. Di Marzo, V., Berrendero, F., Bisogno, T., Gonzalez, S., Cavaliere, P., Romero, J., Cebeira, M., Ramos, J.A. & Fernandez-Ruiz, J.J. (2000) Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of D9-tetrahydrocannabinol-tolerant rats. J. Neurochem., 74, 1627-1635.
17. Di Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Batkai, S., Jarai, Z., Fezza, F., Miura, G.I., Palmiter, R.D., Sugiura, T. & Kunos, G. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature, 410, 822-825.
18. Fattore, L., Spano, M.S., Cossu, G., Deiana, S. & Fratta, W. (2003) Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur. J. Neurosci., 17, 1723-1726.
19. Felder, C.C., Nielsen, A., Briley, E.M., Palkovits, M., Priller, J., Axelrod, J., Nguyen, D.N., Richardson, J.M., Riggin, R.M., Koppel, G.A., Paul, S.M. & Becker, G.W. (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett., 393, 231-235.
20. Freund, T.F. & Hajos, N. (2003) Excitement reduces inhibition via endocannabinoids. Neuron, 38, 362-365.
21. Gerdeman, G.L., Partridge, J.G., Lupica, C.R. & Lovinger, D.M. (2003) It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci., 26, 184-192.
22. Giuffrida, A., Parsons, L.H., Kerr, T.M., Rodriguez de Fonseca, F., Navarro, M. & Piomelli, D. (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci., 2, 358-363.
23. Gonzalez, S., Bisogno, T., Wenger, T., Manzanares, J., Milone, A., Berrendero, F., Di Marzo, V., Ramos, J.A. & Fernandez-Ruiz, J.J. (2000) Sex steroid influence on cannabinoid CB(I) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem. Biophys. Res. Commun., 270, 260-266.
24. Gonzalez, S., Fernandez-Ruiz, J.J., Sparpagliane, V., Parolaro, D. & Ramos, J.A. (2002) Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels. Drug Alcoh. Depend., 66, 77-84.
25. Gonzalez, S., Schmid, P.C., Fernandez-Ruiz, J., Krebsbach, R., Schmid, H.H. & Ramos, J.A. (2003) Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats. Addict. Biol., 8, 159-166.
26. Hajos, N. & Freund, T.F. (2002) Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem. Phys. Lipids, 121, 73-82.
27. Heffner, T.G., Hartman, J.A. & Seiden, L.S. (1980) A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav., 13, 453-456.
28. Kirkham, T.C., Williams, C.M., Fezza, F. & Di Marzo, V. (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol., 136, 550-557.
29. Lamarque, S., Taghzouti, K. & Simon, H. (2001) Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction. Neuropharmacology, 41, 118-129.
30. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B., Vassart, G., Fratta, W. & Parmentier, M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401-404.
31. Lichtman, A.H., Hawkins, E.G., Griffin, G. & Cravatt, B.F. (2002) Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. Pharmacol. Exp. Ther., 302, 73-79.
32. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R. & Compton, D.R. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 83-90.
33. Navarro, M., Carrera, M.N., Fratta, W., Valverde, O., Cossu, G., Fattore, L., Chowen, J.A., Gomez, R., Del Arco, I., Villanua, M.A., Maldonado, R., Koob, G.F. & De Fonseca, F.R. (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J. Neurosci., 21, 5344-5350.
34. Pontieri, F.E., Monnazzi, P., Scontrini, A., Buttarelli, F.R. & Patacchioli, F.R. (2001a) Behavioral sensitization to heroin by cannabinoid pretreatment in the rat. Eur. J. Pharmacol., 421, R1-R3.
35. Pontieri, F.E., Monnazzi, P., Scontrini, A., Buttarelli, F.R. & Patacchioli, F.R. (2001b) Behavioral sensitization to WIN55212.2 in rats pretreated with heroin. Brain. Res., 898, 178-180.
36. Robbins, T.W. & Everitt, B.J. (2002) Limbic-striatal memory systems and drug addiction. Neurobiol. Learn. Mem., 78, 625-636.
37. Robinson, T.E. & Berridge, K.C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev., 18, 247-291.
38. Rodriguez de Fonseca, F., Del Arco, I., Martin-Calderon, J.L., Gorriti, M.A. & Navarro, M. (1998) Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol. Dis., 5, 483-501.
39. Romero, J., Fernandez-Ruiz, J.J., Vela, G., Ruiz-Gayo, M., Fuentes, J.A. & Ramos, J.A. (1998) Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTPgS binding in morphine-dependent mice. Drug Alcoh. Depend., 50, 241-249.
40. Rubino, T., Tizzoni, L., Viganò, D., Massi, P. & Parolaio, D. (1997) Modulation of rat brain cannabinoid receptors after chronic morphine treatment. Neuroreport, 8, 3219-3223.
41. Schmid, P.C., Krebsbach, R.J., Perry, S.R., Dettmer, T.M., Maasson, J.L. & Schmid, H.H.O. (1995) Occurrence and postmortem generation of anandamide and other long-chain N-acylethanol-amines in mammalian brain. FEBS Lett., 375, 117-120.
42. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A. & Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 215, 89-97.
43. Valenti, M., Vigano, D., Casico, M.G., Rubino, T., Steardo, L., Parolaro, D. & Di Marzo, V. (2004) Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell Mol. Life Sci., 61, 945-950.
44. Van der Stelt, M. & Di Marzo, V. (2003) The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur. J. Pharmacol., 480, 133-150.
45. Viganò, D., Cascio, M.G., Rubino, T., Fezza, F., Vaccani, A., Di Marzo, V. & Parolaio, D. (2003) Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. Neuropsychopharmacology, 28, 1160-1167.
46. Volkow, N.D. & Fowler, J.S. (2000) Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex, 10, 318-325.
47. Vorel, S.R., Liu, X., Hayes, R.J., Spector, J.A. & Gardner, E.L. (2001) Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science, 292, 1175-1178.
48. Wang, L., Liu, J., Harvey-White, J., Zimmer, A. & Kunos, G. (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl Acad. Sci. USA, 100, 1393-1398.
49. Yamaguchi, T., Hagiwara, Y., Tanaka, H., Sugiura, T., Waku, K., Shoyama, Y., Watanabe, S. & Yamamoto, T. (2001) Endrogenous cannabinoid, 2-arachidonoylglycerol, attenuates paloxone-precipitated withdrawal signs in morphine-dependent mice. Brain Res., 909, 121-126.